Trial intelligence / Profile preview

Coenzyme Q10 for idiopathic asthenozoospermia

2005-006105-40Phase 3Completed

Sponsor
Azienda Ospedaliero-Universitaria delle Marche
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in idiopathic asthenozoospermia comparing Coenzyme Q10 with Placebo (2 arms). Primary endpoints: Sperm motility variations at 6 months and Coenzyme Q10 levels in semen at 6 months. Started Aug 2006; status: completed.

02

Drugs

coenzyme q10
03

Conditions

idiopathic asthenozoospermia

Beyond the preview

Go deeper on 2005-006105-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-006105-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call